Topic: Innovation
It’s a Startup — and Almost Certainly a Future Acquisition by a Tech Giant
Patent histories show entrepreneurs focused on exit strategy
Robotaxis Aren’t Sure Route to Ride-Hailing Profits
A model weighs vehicle cost and ownership to assess benefits to riders, drivers and companies
Embryo Selection, Polygenic Scoring and Unrealistic Expectations
False hope for instilling disease resistance and desirable traits?
Market Bubbles Aren’t Entirely Irrational Exuberance
A model examines the relationships between innovation, speculation and market values
On Kickstarter, Beware of ‘Feature Fatigue’
Backers like to offer suggestions to a not-quite-finished product
State Tax Credits for Angel Investors Backfire
Good ideas may be scarce, capital to fund them is not
Fixing a Food Bank’s Pandemic Logistics Problem
Enormous growth and a redrawn supply chain required a new system
A Survival Plan for the Developing World’s Tiny Retailers
Technology and mobile finance needed as nanostores’ compete against online behemoths
A Proposal to Improve Surge Pricing
Reduce fares in adjacent areas to draw more drivers to where demand is high
Organic Wines Prevail in an Analysis of French Wine Ratings
Standards vary and organics capture just 4% of world market
In COVID-19, Should the Logistics Tail Have Wagged the Vaccine Dog?
Balancing vaccine efficacy against need to quickly inoculate more people
Quick Quiz — Stuff You Might Know
Academic medical centers, French elections and Chinese garment workers
Could Tech Giants Be Making Our Economy Less Innovative?
With a business model built on fewer employees, their dominance saps dynamism.
Academic Medical Centers Resilient After Cuts
Following Medicare reimbursement rate changes, research actually increased
How Organizational Hierarchy Hinders a Platform Aimed at Worker Collaboration
NASA employees engaged when it was clear their bosses were on board
How Publicly Funded Research Leads to Cancer Drug Trials
Pharmaceutical companies are better able to identify promising new applications for existing drugs